With Livongo, did Zane Burke sell a lemon to Teladoc’s Jason Gorevic?
Was Livongo a good business? As Burke, now CEO of Quantum Health, touts its strength to investors ahead of a potential IPO, should the Livongo-Teladoc history give them pause?
Omada Health raises $192M in Series E funding and Verily’s Onduo snags a payer partner
Omada got funds from two new investors - Fidelity Management & Research Company and aMoon as well as existing ones. Verily's Onduo is bringing its virtual diabetes management platform to an integrated care delivery and health plan that has 6 million members in Pennsylvania, West Virginia, Delaware, and New York.
The Funding Model for Cancer Innovation is Broken — We Can Fix It
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
What will digital health M&A look like in 2022?
After a busy year for digital health, four experts shared their predictions on which sectors will see the most M&A, and which companies are likely to get together in the future.
Glen Tullman’s newest startup raises another $58M
Glen Tullman’s newest healthcare navigation startup, Transcarent, raised another $58 million in funding. The company plans to use the funds to quickly build out its offering for employers.
Livongo founder’s newest venture: a health navigation startup
Livongo Founder Glen Tullman is leading a new healthcare venture. Called Transcarent, the patient navigation platform strikes risk-sharing agreements with employers.
Top digital health exec’s advice to startups: Once you think you “know” you’ve lost the game
After Livongo sold to Teladoc last year, the company’s former president, Dr. Jennifer Schneider, is starting a new chapter on Cityblock’s board of directors. In an interview with MedCity News, she shared more about why she joined Cityblock and lessons learned during her time at Livongo.
presented by
Transforming Patient Care: The Role of AI-Powered Assistants
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
4 takeaways from Teladoc’s earnings
After a year of record growth, Teladoc set expectations for limited growth in its paid memberships and visits in 2021. But the company still sees long-term opportunities with a primary care pilot it is launching and its acquisition of Livongo.
Health-tech funding breaks another record in 2020
Healthcare technology companies raised a record of $15.3 billion in 2020, according to a report from Silicon Valley Bank. For the first time, digital health companies surpassed biopharma for the number of deals.
Newly-minted VC and ex-journalist Chrissy Farr makes some health tech predictions
CNBC's healthcare reporter has left the world of journalism behind to become a venture capitalist at OMERS Ventures. In an interview, she makes some healthcare predictions about 2021 and beyond.
Teladoc, Livongo finalize $18.5B merger
The two companies finalized their merger on Friday, with Livongo becoming a subsidiary of Teladoc. Shareholders overwhelmingly approved the deal on Thursday.
presented by
Market Trends to Watch for Health Systems and Their Specialty Pharmacies
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Livongo’s top leaders to depart after Teladoc merger
After Teladoc and Livongo merge, several of the company’s top executives, including CEO Zane Burke and President Dr. Jennifer Schneider, will leave the combined company, according to a recent filing.
Teladoc, Livongo land first joint contract
The companies made their first cross-sale to Guidewell Health, the parent company of Florida Blue. Livongo’s diabetes platform will become available to 50,000 of the insurer’s members.
2020 may be the year from hell, but health tech IPO boom continues
Despite the Covid-19 pandemic, rising unemployment, and 2020’s other woes, healthcare technology firms continue to go public. So far, six health tech firms have already gone public in 2020.
Teladoc-Livongo point the way to a consumer-first health ecosystem but also further fragmentation
The rise of digital in the health care ecosystem is also making the consumer experience increasingly fragmented and overly complex.
The deal was “inevitable” and other takeaways from the massive $18.5B Livongo-Teladoc merger
The two fast-growing digital health companies struck a merger agreement on Wednesday. Teladoc will acquire Livongo in a deal that would value the startup at a whopping $18.5 billion.